SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000902664-22-001530
Filing Date
2022-02-11
Accepted
2022-02-11 10:09:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 POINT BIOPHARMA GLOBAL INC. p22-0505sc13ga.htm SC 13G/A 57099
  Complete submission text file 0000902664-22-001530.txt   58766
Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

IRS No.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182
POINT Biopharma Global Inc. (Subject) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91575 | Film No.: 22617379
SIC: 2834 Pharmaceutical Preparations